Bayer completes sale of animal health business to Elanco
Bayer has wrapped up its previously announced $7.6 billion sale of its animal health business division to US-based…
Siemens Healthineers to acquire cancer care technologies developer Varian Medical Systems
Siemens Healthineers acquisition of Varian Medical Systems : Germany-based Siemens Healthineers has signed an all-cash deal worth around…
Sanofi, GSK to supply 60 million doses of COVID-19 vaccine to UK
Pharma majors Sanofi and GlaxoSmithKline (GSK) have reached an agreement with the UK government for supplying up to…
UCB signs $2bn worth deal with Roche for AD drug candidate UCB0107
Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its…
Pfizer, BioNTech begin phase 2/3 BNT162b2 COVID-19 vaccine trial
BNT162b2 COVID-19 vaccine trial : Pfizer and BioNTech have advanced their BNT162b2 COVID-19 vaccine candidate into phase 2/3…
PCI Pharma Services to open new clinical center of excellence in Berlin
PCI Pharma Services, a drug development solutions provider, is set to expand its global clinical trial services with…
AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062
AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development…
AstraZeneca strikes $6bn worth deal for Daiichi Sankyo’s DS-1062
AstraZeneca has signed a deal potentially worth up to $6 billion with Daiichi Sankyo for the global development and commercialization for the latter’s DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC), which is being developed for the treatment of multiple tumor types. Daiichi Sankyo is developing the antibody drug conjugate for multiple tumors […]
PIPE-505 : Pipeline Therapeutics initiates phase 1/2a SNHL trial
Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor…
CHMP adopts positive opinion for avapritinib for PDGFRA D842V mutant GIST
US precision therapy company Blueprint Medicines said that the Committee for Medicinal Products for Human Use (CHMP) of…